Video

Unmet Needs and Treatment Challenges in Ulcerative Colitis

Author(s):

Maia Kayal, MD,David P. Hudesman, MD

An expert in gastroenterology shares her opinion on the current unmet needs and treatment challenges for patients with ulcerative colitis.

Related Videos
Wendy Wright, DNP, an expert on fibromyalgia
Andrea Banty, NP, DNP
Wendy Wright, DNP, an expert on fibromyalgia
Wendy Wright, DNP, an expert on fibromyalgia
1 KOL is featured in this series.
1 KOL is featured in this series.
Dennis M. Marcus, MD , an expert on neovascular AMD
1 KOL is featured in this series.
1 KOL is featured in this Insights series.
Dennis M. Marcus, MD , an expert on neovascular AMD
Related Content
FDA black and white logo | Credit: US Food and Drug Administration
September 11th 2024

FDA Approves Guselkumab (Tremfya) for Ulcerative Colitis

Abigail Brooks, MA
Reaction to the Historic Approval of RBX2660
December 26th 2022

Reaction to the Historic Approval of RBX2660

Kenny Walter
Gilaad Kaplan, MD, MPH | Credit: University of Calgary
July 22nd 2024

Risankizumab Induction, Maintenance Therapy Improves Clinical Remission Rates in UC

Abigail Brooks, MA
Marla Dubinsky, MD: The Future of IL-23 Treatments for IBD
September 30th 2022

Marla Dubinsky, MD: The Future of IL-23 Treatments for IBD

Kenny Walter
Bruce Sands, MD | Credit: Aimentiv
June 28th 2024

Ozanimod Effective, Durable in Patients with Ulcerative Colitis Naive to Advanced Therapy

Abigail Brooks, MA
FDA black and white logo | Credit: US Food and Drug Administration
June 18th 2024

FDA Approves Risankizumab (Skyrizi) for Ulcerative Colitis

Abigail Brooks, MA
© 2024 MJH Life Sciences

All rights reserved.